REVENUE INTEREST AGREEMENT Dated as of May 10, 2018 Between LA JOLLA PHARMA, LLC, as Product Sub and THE ENTITIES MANAGED BY HEALTHCARE ROYALTY MANAGEMENT, LLC IDENTIFIED HEREIN, collectively as InvestorRevenue Interest Agreement • May 14th, 2018 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • New York
This REVENUE INTEREST AGREEMENT (this “Agreement”) dated as of May 10, 2018 (the “Effective Date”), is entered into by and between and the entities managed by HealthCare Royalty Management, LLC set forth on Annex I (collectively, the “Investor”), and La Jolla Pharma, LLC, a Delaware limited liability company (“Product Sub”).
